Ajanta Pharma has informed that the 46th Annual General Meeting (AGM) of the company was held on Thursday, 17th July 2025 at 11.00 am through Video Conferencing /Other Audio-Visual Means. The company has informed that AGM proceedings have been submitted separately. Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has submitted the following: a. Details of voting results through remote e-voting and at the AGM on each of the resolutions set out in the notice; b. Consolidated Scrutinizer’s Report dated 17th July 2025 on remote e-voting and at the AGM. The above results are uploaded on the website of the company at www.ajantapharma.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1282.15 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 960.00 |
| Lupin | 2249.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: